top headlines
HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]
Amorphical has completed patient enrolment in a Phase 2 trial [...]
Movers & Shakers
sponsored content
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
Other news
ProBioGen and VarmX have entered a collaboration to develop a [...]
A €2.5 million Horizon Europe-backed project will develop higher-resolution quantum-enhanced [...]
China’s growing biotechnology sector is facing increased scrutiny from US [...]
Medicus Pharma has received FDA clearance to begin a Phase [...]
ViiV Healthcare’s two-drug HIV regimen Dovato was non-inferior to the [...]
Seegene analysis of about 60,000 test results found STI pathogens [...]
